We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Targets Savings From Manufacturing Efficiencies
GSK Targets Savings From Manufacturing Efficiencies
November 7, 2007
A substantial portion of the cost savings GlaxoSmithKline (GSK) expects to derive from its restructuring will result from manufacturing efficiencies as the firm plans to outsource production of off-patent drugs and reduce production sites and staff.